MediciNova Receives Notice of Allowance for Second Patent Covering MN-166 (ibudilast) for the Treatment of Glioblastoma

NEXT STORY
PM360 Adds Nine New Members to Editorial Advisory Board
PREV STORY
Kite Realty Group Trust Launches KRG Small Business Loan Program for Tenants
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

UPDATE — Nuance Expands Vision and Capabilities for Next Generation AI Powered Virtual Assistants for Healthcare

Company showcases unified vision for ambient clinical documentation and announces general availability of virtual ...

author_avatar
NASDAQ Market News

Replimune Announces FDA Acceptance of Investigational New Drug Application for its Lead Oncolytic Immunotherapy Candidate, RP1

WOBURN, Mass., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Replimune Group Inc. (NASDAQ: REPL), a ...

author_avatar
NASDAQ Market News

TopiVert Pharma Limited: Positive results from TOP1288 Phase 1 study

LONDON, UNITED KINGDOM--(Marketwired - Jan 8, 2018) - TopiVert Pharma Ltd TopiVert announces positive ...

author_avatar
NASDAQ Market News